These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20470667)

  • 21. Ototoxicity of intratympanic docusate sodium and mineral oil in the guinea pig.
    Nader ME; Saliba I
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):455-60. PubMed ID: 22101097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the protective effects of intratympanic dexamethasone and methylprednisolone against cisplatin-induced ototoxicity.
    Özel HE; Özdoğan F; Gürgen SG; Esen E; Genç S; Selçuk A
    J Laryngol Otol; 2016 Mar; 130(3):225-34. PubMed ID: 26830667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of protective agents against cisplatin ototoxicity.
    Rybak LP; Husain K; Morris C; Whitworth C; Somani S
    Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetylcysteine attenuates noise-induced permanent hearing loss in diabetic rats.
    Wu HP; Hsu CJ; Cheng TJ; Guo YL
    Hear Res; 2010 Aug; 267(1-2):71-7. PubMed ID: 20430080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosing study on the effectiveness of salicylate/N-acetylcysteine for prevention of noise-induced hearing loss.
    Coleman J; Huang X; Liu J; Kopke R; Jackson R
    Noise Health; 2010; 12(48):159-65. PubMed ID: 20603572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antioxidant treatment reduces blast-induced cochlear damage and hearing loss.
    Ewert DL; Lu J; Li W; Du X; Floyd R; Kopke R
    Hear Res; 2012 Mar; 285(1-2):29-39. PubMed ID: 22326291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratympanic administration of methylprednisolone reduces impact of experimental intensive impulse noise trauma on hearing.
    Zhou Y; Zheng H; Shen X; Zhang Q; Yang M
    Acta Otolaryngol; 2009 Jun; 129(6):602-7. PubMed ID: 18815936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model.
    Hughes AL; Hussain N; Pafford R; Parham K
    Otolaryngol Head Neck Surg; 2014 Jan; 150(1):115-20. PubMed ID: 24233060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ototoxic effect of topical ciclopirox as an antimycotic preparation.
    Baylancicek S; Serin GM; Ciprut A; Sari M; Akdaş F; Tutkun A
    Otol Neurotol; 2008 Oct; 29(7):910-3. PubMed ID: 18698269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of intratympanic infiltration of N-acetyl cysteine in cisplatin ototoxicity].
    Rosas-Gutiérrez GDC; Fernández-Hernández JP; Olea-González AI
    Rev Med Inst Mex Seguro Soc; 2023 Sep; 61(Suppl 2):S318-S322. PubMed ID: 38016189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intratympanic application of aminoglycosides on click-evoked myogenic potentials in Guinea pigs.
    Day AS; Lue JH; Yang TH; Young YH
    Ear Hear; 2007 Feb; 28(1):18-25. PubMed ID: 17204896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
    Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
    Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
    Hill GW; Morest DK; Parham K
    Otol Neurotol; 2008 Oct; 29(7):1005-11. PubMed ID: 18716567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.
    Gunes D; Kirkim G; Kolatan E; Guneri EA; Ozogul C; Altun Z; Serbetcioglu B; Yilmaz O; Aktas S; Mutafoglu K; Tufekci O; Erbayraktar Z; Olgun N
    Chemotherapy; 2011; 57(3):186-94. PubMed ID: 21525749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin-Induced Ototoxicity and the Effects of Intratympanic Diltiazem in a Mouse Model.
    Naples JG; Parham K
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):144-9. PubMed ID: 26419839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
    Rolland V; Meyer F; Guitton MJ; Bussières R; Philippon D; Bairati I; Leclerc M; Côté M
    J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):4. PubMed ID: 30651130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial.
    Sarafraz Z; Ahmadi A; Daneshi A
    Int Tinnitus J; 2018 Jun; 22(1):40-45. PubMed ID: 29993216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats.
    Paksoy M; Ayduran E; Sanlı A; Eken M; Aydın S; Oktay ZA
    Med Oncol; 2011 Jun; 28(2):615-21. PubMed ID: 20300971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.